Table 4.
Comparison of the remission rate in different b/tsDMARDs
| Remission criteria | TNFi n=153 | IL-6i n=95 | Anti-CD20 mAb n=51 | CTLA4-Ig n=36 | JAKi n=19 | P value |
|---|---|---|---|---|---|---|
| DAS28-ESR, n (%) | 71 (47•0) | 59 (62•8) | 29 (56•9) | 17 (47•2) | 9 (47•4) | 0•15 |
| DAS28-CRP, n (%) | 115 (76•2) | 73 (78•5) | 32 (66•7) | 28 (77•8) | 11 (64•7) | 0•46 |
| CDAI, n (%) | 73 (49•0) | 39 (41•5) | 27 (52•9) | 20 (55•6) | 6 (33•3) | 0•34 |
| SDAI, n (%) | 70 (47•3) | 39 (42•4) | 24 (50•0) | 20 (55•6) | 6 (33•3) | 0•50 |
| Boolean, n (%) | 74 (48•7) | 34 (36•2) | 23 (47•9) | 19 (52•8) | 7 (36•8) | 0•25 |
| CliDR, n (%) | 45 (29•4) | 31 (33•0) | 20 (40•0) | 10 (27•8) | 4 (21•1) | 0•51 |